UK guidelines for the management of bone sarcomas

被引:169
作者
Gerrand, Craig [1 ]
Athanasou, Nick [2 ]
Brennan, Bernadette [3 ]
Grimer, Robert [4 ]
Judson, Ian [5 ]
Morland, Bruce [6 ]
Peake, David [7 ]
Seddon, Beatrice [8 ]
Whelan, Jeremy [8 ]
机构
[1] Freeman Rd Hosp, Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England
[2] Nuffield Orthopaed Ctr, Oxford OX3 7LD, England
[3] Royal Manchester Childrens Hosp, Manchester M13 9WL, Lancs, England
[4] Royal Orthopaed Hosp, Birmingham B31 2AP, W Midlands, England
[5] Royal Marsden, Sutton SM2 5PT, Surrey, England
[6] Birmingham Childrens Hosp, Birmingham B4 6NH, W Midlands, England
[7] Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England
[8] Univ Coll Hosp, London NW1 2PG, England
关键词
D O I
10.1186/s13569-016-0047-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This document is an update of the British Sarcoma Group guidelines published in 2010. The aim is to provide a reference standard for the clinical care of patients in the UK with bone sarcomas. Recent recommendations by the European Society of Medical Oncology, The National Comprehensive Cancer Network and The National Institute for Health and Care Excellence have been incorporated, and the literature since 2010 reviewed. The standards represent a consensus amongst British Sarcoma Group members in 2015. It is acknowledged that these guidelines will need further updates as care evolves. The key recommendations are that bone pain or a palpable mass should always lead to further investigation and that patients with clinico-radiological findings suggestive of a primary bone tumour at any site in the skeleton should be referred to a specialist centre and managed by a fully accredited bone sarcoma multi-disciplinary team. Treatment recommendations are provided for the major tumour types and for localised, metastatic and recurrent disease. Follow up schedules are suggested.
引用
收藏
页数:21
相关论文
共 172 条
[1]   Tumour volume as a predictor of necrosis after chemotherapy in Ewing's sarcoma [J].
Abudu, A ;
Davies, AM ;
Pynsent, PB ;
Mangham, DC ;
Tillman, RM ;
Carter, SR ;
Grimer, RJ .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1999, 81B (02) :317-322
[2]   Health Status at Long-Term Follow-Up in Patients Treated for Extremity Localized Ewing Sarcoma or Osteosarcoma: A Scandinavian Sarcoma Group Study [J].
Aksnes, L. H. ;
Bauer, H. C. F. ;
Dahl, A. A. ;
Fossa, S. D. ;
Hjorth, L. ;
Jebsen, N. ;
Lernedal, H. ;
Hall, K. Sundby .
PEDIATRIC BLOOD & CANCER, 2009, 53 (01) :84-89
[3]   High-BMI at Diagnosis Is Associated With Inferior Survival in Patients With Osteosarcoma: A Report From the Children's Oncology Group [J].
Altaf, Sadaf ;
Enders, Felicity ;
Jeavons, Elysia ;
Krailo, Mark ;
Barkauskas, Donald A. ;
Meyers, Paul ;
Arndt, Carola .
PEDIATRIC BLOOD & CANCER, 2013, 60 (12) :2042-2046
[4]   Accuracy of computed tomography guided core needle biopsy of musculoskeletal tumours [J].
Altuntas, AO ;
Slavin, J ;
Smith, PJ ;
Schlict, SM ;
Powell, GJ ;
Ngan, S ;
Toner, G ;
Choong, PFM .
ANZ JOURNAL OF SURGERY, 2005, 75 (04) :187-191
[5]   Bone-Seeking Radiopharmaceuticals as Targeted Agents of Osteosarcoma: Samarium-153-EDTMP and Radium-223 [J].
Anderson, Peter M. ;
Subbiah, Vivek ;
Rohren, Eric .
CURRENT ADVANCES IN OSTEOSARCOMA, 2014, 804 :291-304
[6]   The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols [J].
Andreou, D. ;
Bielack, S. S. ;
Carrle, D. ;
Kevric, M. ;
Kotz, R. ;
Winkelmann, W. ;
Jundt, G. ;
Werner, M. ;
Fehlberg, S. ;
Kager, L. ;
Kuehne, T. ;
Lang, S. ;
Dominkus, M. ;
Exner, G. U. ;
Hardes, J. ;
Hillmann, A. ;
Ewerbeck, V. ;
Heise, U. ;
Reichardt, P. ;
Tunn, P. -U. .
ANNALS OF ONCOLOGY, 2011, 22 (05) :1228-1235
[7]  
[Anonymous], [No title captured]
[8]  
[Anonymous], 2015, QUAL STAND QS78 SARC
[9]  
[Anonymous], 2014, QUAL STAND QS55 YOUN
[10]  
[Anonymous], 2015, SUSC CANC REC REF NI